Analystreport

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) had its price target lowered by analysts at Bank of America Co. from $37.00 to $34.00. They now have a "buy" rating on

Kiniksa Pharmaceuticals, Ltd. - Class A  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm Check Earnings Report